This webinar will explore what comes next for malaria vaccine development and access. Experts will discuss the future pipeline of malaria vaccines, the challenges and opportunities in integrating vaccines into immunization programs, and the complexities of forecasting and manufacturing supply to meet demand. Join PATH for a dynamic discussion on how these factors shape equitable access and the global effort to reduce malaria’s burden.
Search
MEMBERS
- 19Labs
- AbbVie
- Accenture
- Africa Health Business
- AIfluence
- Airbnb
- Americares
- Ananya Health
- Antara International
- Baraka Impact Finance
- Boston Consulting Group
- CCBRT
- Cepheid
- Chevron
- Clinton Global Initiative
- Connective Impact
- Consortium of Universities for Global Health
- Cross-Border Impact Ventures
- Ending Pandemics
- ETR
- Fistula Foundation
- Friends of Chidamoyo
- Friends of the Global Fight
- GAIA Global Health
- Gilead Sciences
- Global Environment & Technology Foundation
- Global Fund for Women
- Global Health Corps
- Global Health Council
- Global Health Technologies Coalition
- Global Impact Advisors
- Global Strategies
- HealthAI
- Hesperian Health Guides
- HOPO Therapeutics
- Ideo.org
- Ipas
- John Snow, Inc.
- Kainomyx
- Kapnek Trust USA
- Kupona Foundation
- L.E.K. Consulting
- LivingGoods
- Mastercard
- Maya Health Alliance
- Medicines360
- MedShare
- Merck
- Meta
- Nivi
- North Carolina Global Health Alliance
- OmniVis
- OPHID
- PATH
- Pathfinder International
- Pendulum
- Pfizer
- Planetary Health Alliance
- Population Services International
- Public Health Institute
- Resonance
- ReSurge International
- Roche Diagnostics
- Sabin Vaccine Institute
- San Francisco Community Health Center
- Seed Global Health
- Simprints
- Stanford University
- — Stanford University Byers Center for Biodesign
- — Stanford University Center for Innovation in Global Health
- — Stanford University School of Medicine
- Street Business School
- Tiba Foundation
- UK Science & Innovation Network
- UNICEF
- University of California
- — UC Berkeley
- — UC Berkeley Center for Emerging and Neglected Diseases
- — UC Berkeley Haas School of Business
- — UC Berkeley School of Public Health
- — UC Davis
- — UC Davis Institute for Pandemic Intelligence
- — UC Global Health Institute
- — UCSF
- — UCSF Institute for Global Health Sciences
- UpSwell
- Viamo
- Vir Biotechnology
- Washington Global Health Alliance
- Watsi
- World Health Organization
- World Telehealth Initiative
- YLabs
- Zenysis
TOPICS
REGIONS
- Africa
- — Cameroon
- — Côte d’Ivoire
- — Ethiopia
- — Guinea
- — Kenya
- — Malawi
- — Mozambique
- — Niger
- — Rwanda
- —— Kigali
- Asia
- — Nepal
- — Pakistan
- — Bangladesh
- — Indonesia
- —— Bali
- — Israel
- Europe
- — Switzerland
- —— Geneva
- South America
- — Brazil
- North America
- — California
- —— Berkeley
- —— Los Angeles
- —— Sacramento
- —— San Francisco
- —— Stanford
- — New York
- —— New York City
- — North Carolina
- —— Durham
- — Washington
- —— Seattle
- — Washington D.C.
Should AIDS, TB and Malaria Remain a Focus in Global Health?
Friends of the Global Fight Read More
Medic and Audere Partner With Kenyan and Ugandan Governments to Advance AI-Powered Malaria Diagnostics
Audere Read More
AKU, Local and Global Partners Launch Landmark Malaria Elimination Project in Thatta
Zenysis Read More
Powering Progress: Immunization, Malaria, and What’s Next in Global Health
JSI Read More
Malaria Nearly Took My Life. Innovation May Be What Finally Ends It, If We Let It.
GHTC Read More
A Total of USD 12.7 Million Investment in New Diagnostics and Drug Development for NTDs and Malaria to Partners
DNDi, PATH Read More
2024 Was a Milestone Year for Tackling Malaria in the Central African Republic. Here’s Why.
AMP Health Read More
New Baseline Study: Biometrically Verifying Malaria Vaccine Delivery in Ghana
Simprints Read More
UCSF’s Malaria Elimination Initiative Receives New Funding to Advance Elimination Goals
UCSF Read More
Dr. Reddy’s Laboratories, Aurigene Pharmaceutical Services, and Kainomyx Announce Potential Partnership for Joint Development of Affordable Anti-Malarial Drug
Kainomyx Read More
A proactive approach to fighting malaria within communities
PATH Read More
How the first malaria vaccine cleared the way for a second
PATH Read More
AIDS 2024: Scaling public-private partnerships in prevention and behaviour change
Join the Bureau of Global Health Security and Diplomacy, The Global Fund to Fight AIDS, Tuberculosis and Malaria, United States Agency for International Development, Bill & Melinda Gates Foundation, Johnson and Johnson and Project Last Mile for a satellite session at AIDS 2024 on July 22, 2024 at 11:30 AM CET. This satellite session will focus on highlighting examples of partnerships that are creating impact in prevention and behavior change for improved program delivery across key health priorities including HIV, TB and Malaria. The session will tackle topics such as: how to effectively leverage consumer insights to address HIV and TB, components for launching successful PPPs, challenges of effective prevention and behavior change programs for HIV and TB including barriers and opportunities to scale behavior-focused prevention.
Tailoring malaria interventions to high–risk groups in Senegal
PATH Read More
5 actions for a malaria-free world
UNICEF Read More
Health Beyond Healthcare: Building a Healthier, Climate-Resilient Future for All
PSI Read More
Helping mothers fight back against malaria
PATH Read More
20 years of partnership and impact against malaria
PATH Read More
Embedding Quality Case Management Into Communities
Join Population Services International for the second part of their Greater Mekong Subregion Elimination of Malaria through Surveillance (GEMS/GEMS+) learning series, exploring how we can make private sector data work to achieve malaria elimination. Learn how their GEMS/GEMS+ project engaged diverse and hard to reach communities for more effective interventions.